Inhibition of hormone-induced Ca 2+ release from intracellular stores by cGMP involves a protein complex which consists of at least 3 proteins, i.e. the inositol-1,3,4-phosphat receptor (IP 3 R), the cGMP-dependent protein kinase (cGK), and, as a linker protein between both, the inositol-1,3,4-phosphat receptor associated G-kinase substrate (IRAG [1]). Recently, mutant mice were created which lack the part of the IRAG protein that is supposed to mediate the association between IRAG and the IP 3 R. In these mice (IRAG ∆12 mice), cGMP failed to attenuate both, hormone-induced Ca2+ signals and hormone-induced contractions in vascular preparations [2] . These result confirm the concept that IRAG is an essential mediator of relaxation mediated by cGMP/cGK signalling in vascular smooth muscle.
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In the present study, we tested this hypothesis in two other smooth muscle types, i.e. from jejunum and colon. In line with the concept above, cGMP failed to relax hormone-induced contractions in colon muscle from IRAG ∆12 mice. In contrast, cGMP clearly relaxed hormoneinduced contractions in jejunum muscle from these mutant mice. Thus, Rho/Rho kinase rather than IRAG seems to be the key player in mediating cGMP/cGK signalling in this particular type of smooth muscle.
Next, we questioned whether the mutation of IRAG affects the relaxant effects of cGMP on hormone-independent contractions. For this purpose, muscles were contracted by activation of Ca 2+ influx, either by depolarisation with high K + or by initiating capacitative Ca 2+ entry with thapsigargin. Since IRAG is mainly associated with sarcoplasmatic membrane proteins, we expected that the IRAG mutation would not affect cell membrane Ca 2+ signalling. Surprisingly, the relaxant effects of cGMP on these types of contraction were attenuated in intestinal muscles from IRAG ∆12 mice.
The results suggests that (1) the association of IRAG/IP 3 R determines cGMP/cGK-mediated relaxations only in distinct types of smooth muscle, and (2) IRAG participates in cGMP/cGK-mediated relaxation not only during hormone-induced Ca 2+ release but also during hormoneindependent Ca 2+ entry. Thus, cGMP/cGK may target via IRAG, either alone or with the IP 3 R, to, at present, unidentified elements of the Ca 2+ entry machinery in certain types of smooth muscle.
